nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP2J2—blood vessel—malignant glioma	0.0219	0.123	CbGeAlD
Masoprocol—IGF1R—embryo—malignant glioma	0.0193	0.109	CbGeAlD
Masoprocol—IGF1R—brainstem—malignant glioma	0.0176	0.0994	CbGeAlD
Masoprocol—IGF1R—telencephalon—malignant glioma	0.0157	0.0882	CbGeAlD
Masoprocol—CYP2J2—telencephalon—malignant glioma	0.0106	0.0598	CbGeAlD
Masoprocol—IGF1R—central nervous system—malignant glioma	0.0089	0.0502	CbGeAlD
Masoprocol—IGF1R—cerebellum—malignant glioma	0.0087	0.049	CbGeAlD
Masoprocol—LTB4R—brain—malignant glioma	0.00856	0.0482	CbGeAlD
Masoprocol—CYP2J2—medulla oblongata—malignant glioma	0.00834	0.047	CbGeAlD
Masoprocol—CYP2J2—midbrain—malignant glioma	0.00762	0.043	CbGeAlD
Masoprocol—CYP2J2—spinal cord—malignant glioma	0.00744	0.0419	CbGeAlD
Masoprocol—IGF1R—brain—malignant glioma	0.00707	0.0398	CbGeAlD
Masoprocol—CYP2J2—central nervous system—malignant glioma	0.00603	0.034	CbGeAlD
Masoprocol—CYP2J2—cerebellum—malignant glioma	0.0059	0.0332	CbGeAlD
Masoprocol—CYP2J2—brain—malignant glioma	0.00479	0.027	CbGeAlD
Masoprocol—ALOX5—central nervous system—malignant glioma	0.00475	0.0268	CbGeAlD
Masoprocol—ALOX5—cerebellum—malignant glioma	0.00465	0.0262	CbGeAlD
Masoprocol—ALOX5—brain—malignant glioma	0.00377	0.0213	CbGeAlD
Masoprocol—CYP19A1—central nervous system—malignant glioma	0.00329	0.0185	CbGeAlD
Masoprocol—CYP19A1—brain—malignant glioma	0.00261	0.0147	CbGeAlD
Masoprocol—IGF1R—Signaling Pathways—GFAP—malignant glioma	0.000442	0.000537	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JAG2—malignant glioma	0.000437	0.000531	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BAD—malignant glioma	0.000433	0.000526	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPHK1—malignant glioma	0.000428	0.00052	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000425	0.000517	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2B6—malignant glioma	0.000424	0.000516	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HEY1—malignant glioma	0.000419	0.000509	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR4—malignant glioma	0.000419	0.000509	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIST1H3B—malignant glioma	0.000407	0.000495	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—IDH2—malignant glioma	0.000402	0.000489	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0004	0.000486	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—AKT1—malignant glioma	0.000395	0.00048	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BRAF—malignant glioma	0.000394	0.000479	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—IDH1—malignant glioma	0.000388	0.000472	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000387	0.000471	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000379	0.000461	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2B6—malignant glioma	0.000378	0.00046	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SPHK1—malignant glioma	0.000375	0.000456	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JAG2—malignant glioma	0.000372	0.000452	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—H3F3A—malignant glioma	0.00037	0.00045	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2C18—malignant glioma	0.000368	0.000447	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—F2—malignant glioma	0.000367	0.000446	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCR3—malignant glioma	0.000366	0.000445	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—YWHAE—malignant glioma	0.000356	0.000433	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK2—malignant glioma	0.000356	0.000433	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FLT1—malignant glioma	0.000355	0.000431	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—DUSP6—malignant glioma	0.000353	0.000429	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CG—malignant glioma	0.000351	0.000427	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—JAG1—malignant glioma	0.000349	0.000424	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH3—malignant glioma	0.000347	0.000422	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000347	0.000422	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—IDH1—malignant glioma	0.000346	0.00042	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FBXW7—malignant glioma	0.000342	0.000415	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—malignant glioma	0.000335	0.000407	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BDKRB2—malignant glioma	0.000335	0.000407	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SPHK1—malignant glioma	0.000335	0.000407	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—F2—malignant glioma	0.000333	0.000405	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MDM2—malignant glioma	0.00033	0.000401	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2C18—malignant glioma	0.000328	0.000399	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT2—malignant glioma	0.000322	0.000391	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—COX8A—malignant glioma	0.000322	0.000391	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CG—malignant glioma	0.000319	0.000388	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000316	0.000384	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—H3F3A—malignant glioma	0.000314	0.000382	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PTPN11—malignant glioma	0.000314	0.000381	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCR3—malignant glioma	0.000311	0.000379	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH2—malignant glioma	0.000311	0.000379	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000309	0.000376	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CD—malignant glioma	0.000309	0.000376	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000305	0.000371	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KNG1—malignant glioma	0.000305	0.000371	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—YWHAE—malignant glioma	0.000303	0.000368	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK2—malignant glioma	0.000303	0.000368	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FLT1—malignant glioma	0.000302	0.000367	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—DUSP6—malignant glioma	0.0003	0.000365	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTT1—malignant glioma	0.000297	0.000362	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—JAG1—malignant glioma	0.000296	0.00036	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—malignant glioma	0.000295	0.000359	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH3—malignant glioma	0.000295	0.000359	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT2—malignant glioma	0.000292	0.000355	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK1—malignant glioma	0.00029	0.000353	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FBXW7—malignant glioma	0.00029	0.000353	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000287	0.000349	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BDKRB2—malignant glioma	0.000285	0.000346	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000282	0.000342	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CD—malignant glioma	0.000281	0.000341	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS1—malignant glioma	0.000279	0.000339	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000278	0.000338	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—malignant glioma	0.000278	0.000337	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ASMT—malignant glioma	0.000273	0.000332	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000272	0.00033	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP3—malignant glioma	0.00027	0.000328	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CB—malignant glioma	0.000269	0.000327	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CDKN2B—malignant glioma	0.000268	0.000325	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000267	0.000325	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTT1—malignant glioma	0.000265	0.000322	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH2—malignant glioma	0.000265	0.000322	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTK2—malignant glioma	0.00026	0.000316	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BCHE—malignant glioma	0.000259	0.000315	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KNG1—malignant glioma	0.000259	0.000315	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CXCL8—malignant glioma	0.000259	0.000315	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCAN—malignant glioma	0.000257	0.000312	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC5A5—malignant glioma	0.000256	0.000311	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HES1—malignant glioma	0.000255	0.00031	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NCOR1—malignant glioma	0.000254	0.000309	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—malignant glioma	0.000251	0.000305	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—RAF1—malignant glioma	0.00025	0.000305	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS1—malignant glioma	0.000248	0.000302	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000248	0.000301	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—IL2—malignant glioma	0.000247	0.000301	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK1—malignant glioma	0.000247	0.0003	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CB—malignant glioma	0.000245	0.000297	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDGFRA—malignant glioma	0.000243	0.000296	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000242	0.000294	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00024	0.000292	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SPP1—malignant glioma	0.000236	0.000287	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CXCL8—malignant glioma	0.000235	0.000286	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BCHE—malignant glioma	0.000231	0.000281	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000231	0.00028	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP3—malignant glioma	0.00023	0.000279	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC5A5—malignant glioma	0.000228	0.000277	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDKN2B—malignant glioma	0.000228	0.000277	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000226	0.000274	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL2—malignant glioma	0.000225	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TERT—malignant glioma	0.000224	0.000272	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTK2—malignant glioma	0.000221	0.000269	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDGFB—malignant glioma	0.000218	0.000266	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGFR1—malignant glioma	0.000217	0.000264	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HES1—malignant glioma	0.000217	0.000264	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCOR1—malignant glioma	0.000216	0.000262	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000216	0.000262	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HIF1A—malignant glioma	0.000214	0.00026	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000214	0.00026	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000213	0.000259	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000209	0.000254	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—IDH2—malignant glioma	0.000207	0.000252	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—malignant glioma	0.000207	0.000252	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDGFRA—malignant glioma	0.000207	0.000251	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GSTP1—malignant glioma	0.000206	0.000251	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KDR—malignant glioma	0.000205	0.000249	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SPP1—malignant glioma	0.000201	0.000244	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAT—malignant glioma	0.000201	0.000244	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—F2—malignant glioma	0.000197	0.000239	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FN1—malignant glioma	0.000197	0.000239	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000195	0.000238	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2B6—malignant glioma	0.000195	0.000237	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BAD—malignant glioma	0.000195	0.000237	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH1—malignant glioma	0.000193	0.000234	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TERT—malignant glioma	0.00019	0.000231	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NCOR1—malignant glioma	0.000189	0.00023	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000189	0.00023	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CD80—malignant glioma	0.000189	0.00023	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APC—malignant glioma	0.000189	0.000229	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CG—malignant glioma	0.000189	0.000229	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000186	0.000227	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGF—malignant glioma	0.000186	0.000227	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDGFB—malignant glioma	0.000186	0.000226	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTPN11—malignant glioma	0.000185	0.000225	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGFR1—malignant glioma	0.000185	0.000225	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GSTP1—malignant glioma	0.000184	0.000223	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HIF1A—malignant glioma	0.000182	0.000221	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAT—malignant glioma	0.000179	0.000217	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—IDH1—malignant glioma	0.000178	0.000217	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—BRAF—malignant glioma	0.000177	0.000215	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—malignant glioma	0.000176	0.000214	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KDR—malignant glioma	0.000174	0.000212	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT2—malignant glioma	0.000172	0.00021	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SPHK1—malignant glioma	0.000172	0.00021	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—EGFR—malignant glioma	0.000172	0.000209	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NCOR1—malignant glioma	0.000169	0.000205	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2C18—malignant glioma	0.000169	0.000205	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—F2—malignant glioma	0.000167	0.000204	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FN1—malignant glioma	0.000167	0.000204	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CD—malignant glioma	0.000166	0.000201	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BAD—malignant glioma	0.000166	0.000201	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PIK3CA—malignant glioma	0.000164	0.0002	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH1—malignant glioma	0.000164	0.000199	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—KRAS—malignant glioma	0.000162	0.000197	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CD80—malignant glioma	0.000161	0.000195	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CG—malignant glioma	0.00016	0.000195	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APC—malignant glioma	0.00016	0.000195	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.00016	0.000195	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000159	0.000194	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGF2—malignant glioma	0.000159	0.000193	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGF—malignant glioma	0.000158	0.000193	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTPN11—malignant glioma	0.000157	0.000191	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—malignant glioma	0.000154	0.000188	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—BRAF—malignant glioma	0.000151	0.000183	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PIK3CA—malignant glioma	0.000149	0.000181	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MDM2—malignant glioma	0.000148	0.000181	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RAF1—malignant glioma	0.000148	0.00018	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000148	0.000179	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT2—malignant glioma	0.000147	0.000178	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ERBB2—malignant glioma	0.000146	0.000178	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000145	0.000176	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CB—malignant glioma	0.000144	0.000176	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CD—malignant glioma	0.000141	0.000171	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CG—malignant glioma	0.000141	0.000171	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00014	0.00017	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CXCL8—malignant glioma	0.000139	0.000169	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—malignant glioma	0.000138	0.000167	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTT1—malignant glioma	0.000137	0.000166	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—malignant glioma	0.000136	0.000165	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGF2—malignant glioma	0.000135	0.000164	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—malignant glioma	0.000134	0.000163	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—malignant glioma	0.000133	0.000162	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL2—malignant glioma	0.000133	0.000161	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000132	0.00016	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS1—malignant glioma	0.000128	0.000156	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000128	0.000155	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MDM2—malignant glioma	0.000126	0.000153	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RAF1—malignant glioma	0.000126	0.000153	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MMP9—malignant glioma	0.000126	0.000153	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CG—malignant glioma	0.000125	0.000152	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTEN—malignant glioma	0.000125	0.000152	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ERBB2—malignant glioma	0.000124	0.000151	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CD—malignant glioma	0.000124	0.00015	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CB—malignant glioma	0.000123	0.000149	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—malignant glioma	0.000122	0.000148	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—malignant glioma	0.000121	0.000147	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCHE—malignant glioma	0.000119	0.000145	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CXCL8—malignant glioma	0.000118	0.000143	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC5A5—malignant glioma	0.000118	0.000143	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—malignant glioma	0.000113	0.000137	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL2—malignant glioma	0.000113	0.000137	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—malignant glioma	0.000113	0.000137	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—STAT3—malignant glioma	0.000112	0.000136	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000111	0.000135	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CD—malignant glioma	0.00011	0.000134	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00011	0.000134	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CB—malignant glioma	0.000108	0.000131	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—malignant glioma	0.000107	0.00013	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MMP9—malignant glioma	0.000107	0.00013	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTEN—malignant glioma	0.000106	0.000129	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MYC—malignant glioma	0.000104	0.000126	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—EGFR—malignant glioma	0.000101	0.000123	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CB—malignant glioma	9.61e-05	0.000117	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.61e-05	0.000117	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—malignant glioma	9.59e-05	0.000117	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—KRAS—malignant glioma	9.58e-05	0.000117	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—malignant glioma	9.52e-05	0.000116	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—STAT3—malignant glioma	9.49e-05	0.000115	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GSTP1—malignant glioma	9.47e-05	0.000115	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTEN—malignant glioma	9.32e-05	0.000113	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAT—malignant glioma	9.21e-05	0.000112	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MYC—malignant glioma	8.82e-05	0.000107	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PIK3CA—malignant glioma	8.81e-05	0.000107	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOR1—malignant glioma	8.7e-05	0.000106	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—EGFR—malignant glioma	8.63e-05	0.000105	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—malignant glioma	8.52e-05	0.000104	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTEN—malignant glioma	8.3e-05	0.000101	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—KRAS—malignant glioma	8.15e-05	9.91e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PIK3CA—malignant glioma	7.49e-05	9.1e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—malignant glioma	7.24e-05	8.81e-05	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—malignant glioma	7.19e-05	8.75e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—malignant glioma	7.09e-05	8.62e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.78e-05	8.24e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PIK3CA—malignant glioma	6.57e-05	7.99e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CG—malignant glioma	6.46e-05	7.85e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—malignant glioma	6.24e-05	7.58e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—malignant glioma	6.12e-05	7.44e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PIK3CA—malignant glioma	5.86e-05	7.12e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CD—malignant glioma	5.68e-05	6.9e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—malignant glioma	5.37e-05	6.53e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CB—malignant glioma	4.95e-05	6.02e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—malignant glioma	4.91e-05	5.96e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—malignant glioma	4.79e-05	5.82e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTEN—malignant glioma	4.28e-05	5.2e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PIK3CA—malignant glioma	3.02e-05	3.67e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—malignant glioma	2.47e-05	3e-05	CbGpPWpGaD
